Melanocortin Receptor Binding Conjugates


Disclosed are melanocortin receptor binding conjugates and methods of making and using the foregoing. The melanocortin receptor binding conjugates may comprise an alpha -MSH derivative-Fc immunoglobulin, optionally in combination with a pharmaceutically acceptable carrier. Further disclosed is a method of modulating a biological activity of a melanocortin receptor, comprising contacting the alpha -MSH derivative pharmaceutical composition with the melanocortin receptor. Another aspect disclosed is a method of modulating the melanocortin receptor-mediated condition, comprising administering the pharmaceutical composition of the invention to a patient in need thereof.

Download PDF
Document Preview
Document History
  • Publication: Nov 11, 2010
  • Application: Apr 27, 2010
    WO US 2010/0032501 W
  • Priority: May 7, 2009
    US US 17629409 P
  • Priority: May 6, 2009
    US US 17592109 P

Download Citation

Sign in to the Lens